CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-209,339-238,170-127,337-223,260
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,2353,3982,9961,869
Adjustments To Net Income35,05738,26729,96922,324
Changes In Accounts Receivables-1,859-299857
Changes In Liabilities-534-7,086-101,13252,364
Changes In Inventories-5,484-5,484-5,484-5,484
Changes In Other Operating Activities16,31594-57,78337,894
Total Cash Flow From Operating Activities-159,266-200,286-252,545-107,990
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-789-4,573-6,515-6,164
Investments301156156156
Other Cash flows from Investing Activities----785
Total Cash Flows From Investing Activities-1,188-4,417-6,515-6,949
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings--100,000100,000
Other Cash Flows from Financing Activities---739-1,540
Total Cash Flows From Financing Activities105,421206,787226,179122,689
Effect Of Exchange Rate Changes468-120-39884
Change In Cash and Cash Equivalents-54,5651,964-33,2797,834